By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...

The new injectable form is expected to be more ... to drive growth as patents on older drugs, such as cancer drug Revlimid and blood thinner Eliquis, expire later this decade.

such as cancer drug Revlimid and blood thinner Eliquis, expire later this decade. Opdivo Qvantig was co-formulated with Halozyme Therapeutics' drug delivery technology, which helps reduce treatment ...